XML 34 R22.htm IDEA: XBRL DOCUMENT v3.25.3
Related-Party Transactions
9 Months Ended
Sep. 30, 2025
Related Party Transactions [Abstract]  
Related-Party Transactions

13. Related-Party Transactions

Cleveland Clinic

Cleveland Clinic is a related party because a member of the Company’s board of directors is an executive advisor to Cleveland Clinic. As of September 30, 2025 and December 31, 2024, the Company held current deferred revenue of $45 and $153, respectively from contracts with this client. As of September 30, 2025 and December 31, 2024, amounts due from Cleveland Clinic were $147 and $216, respectively.

During the three months ended September 30, 2025 and 2024, the Company recognized revenue of $177 and $336, respectively, from contracts with this client. During the nine months ended September 30, 2025 and 2024, the Company recognized revenue of $306 and $1,232, respectively, from contracts with this client.

CCAW, JV LLC

CCAW, JV LLC is a related party because it is a joint venture formed between the Company and Cleveland Clinic for which the Company has a minority owned interest in. During 2025, the companies determined that these care services could be provided through partnering between the two entities and that the joint venture was no longer necessary to achieve care delivery. During the quarter ended September 30, 2025, the companies entered into an agreement for the complete liquidation and dissolution of the joint venture. As part of this agreement the Company will continue to support virtual second opinion services that were previously provided by CCAW, JV LLC, though our existing relationship with Cleveland Clinic. Certain business activities will continue through the transition period which will end no later than March 31, 2026.

During the year ended December 31, 2020, the Company made an initial investment in CCAW, JV LLC of $2,940 for its less than 50% interest in the joint venture. During the nine months ended September 30, 2025, the Company made no capital contributions related to a portion of the phase one capital commitment.

As of September 30, 2025 the Company held no current deferred revenue as of and December 31, 2024, the Company held current deferred revenue of $55, from contracts with this client. As of September 30, 2025 and December 31, 2024, there was $1,038 and $400 due from CCAW, JV LLC, respectively.

During the three months ended September 30, 2025 and 2024, the Company recognized revenue of $567 and $406 from contracts with this client, respectively. During the nine months ended September 30, 2025 and 2024, the Company recognized revenue of $1,703 and $1,210, respectively, from contracts with this client.